Eric Smith

Person

New York, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
IL2 and peptide-MHC complex fusion proteins and methods of use thereof
- Patent number 12,091,440
- Issue date Sep 17, 2024
- REGENERON PHARMACEUTICALS, INC.
- Jiaxi Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multispecific antigen-binding molecules for cell targeting and uses...
- Patent number 12,077,603
- Issue date Sep 3, 2024
- REGENERON PHARMACEUTICALS, INC.
- Lauric Haber
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-IL-6 antibody
- Patent number 12,065,488
- Issue date Aug 20, 2024
- Janssen Biotech, Inc.
- Yan Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multispecific antigen-binding molecules for cell targeting and uses...
- Patent number 12,065,508
- Issue date Aug 20, 2024
- REGENERON PHARMACEUTICALS, INC.
- Lauric Haber
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antigen binding molecule formats
- Patent number 11,965,020
- Issue date Apr 23, 2024
- REGENERON PHARMACEUTICALS, INC.
- Tong Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multispecific antigen-binding molecules for cell targeting and uses...
- Patent number 11,952,430
- Issue date Apr 9, 2024
- REGENERON PHARMACEUTICALS, INC.
- Lauric Haber
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Non-human animals expressing humanized CD3 complex
- Patent number 11,937,587
- Issue date Mar 26, 2024
- REGENERON PHARMACEUTICALS, INC.
- Kara L. Olson
- G01 - MEASURING TESTING
Information Patent Grant
Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof
- Patent number 11,905,332
- Issue date Feb 20, 2024
- REGENERON PHARMACEUTICALS, INC.
- David DiLillo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid molecules encoding chimeric antigen receptors targetin...
- Patent number 11,866,478
- Issue date Jan 9, 2024
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric antigen receptors targeting G-protein coupled receptor and...
- Patent number 11,820,806
- Issue date Nov 21, 2023
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human antibodies to human delta like ligand 4
- Patent number 11,820,815
- Issue date Nov 21, 2023
- REGENERON PHARMACEUTICALS, INC.
- Nicholas J. Papadopoulos
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IL2 agonists and methods of use thereof
- Patent number 11,725,034
- Issue date Aug 15, 2023
- REGENERON PHARMACEUTICALS, INC.
- Jiaxi Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies targeting B-cell maturation antigen and methods of use
- Patent number 11,725,059
- Issue date Aug 15, 2023
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antigen binding molecule formats
- Patent number 11,708,407
- Issue date Jul 25, 2023
- REGENERON PHARMACEUTICALS, INC.
- Tong Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific an...
- Patent number 11,633,501
- Issue date Apr 25, 2023
- REGENERON PHARMACEUTICALS, INC.
- John Rudge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid molecules encoding anti-GPRC5D antibodies
- Patent number 11,566,071
- Issue date Jan 31, 2023
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof
- Patent number 11,548,947
- Issue date Jan 10, 2023
- REGENERON PHARMACEUTICALS, INC.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heavy chain constant regions with reduced binding to Fc gamma recep...
- Patent number 11,518,807
- Issue date Dec 6, 2022
- REGENERON PHARMACEUTICALS, INC.
- Samuel Davis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific ant...
- Patent number 11,485,793
- Issue date Nov 1, 2022
- REGENERON PHARMACEUTICALS, INC.
- Lauric Haber
- G01 - MEASURING TESTING
Information Patent Grant
Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof
- Patent number 11,453,721
- Issue date Sep 27, 2022
- Regeneran Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and antibody compositions for tumor treatment
- Patent number 11,434,300
- Issue date Sep 6, 2022
- REGENERON PHARMACEUTICALS, INC.
- Eric Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific anti-CD28 × anti-CD22 antibodies and uses thereof
- Patent number 11,396,544
- Issue date Jul 26, 2022
- REGENERON PHARMACEUTICALS, INC.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof
- Patent number 11,384,153
- Issue date Jul 12, 2022
- Regeneran Pharmaceuticals, Inc.
- Eric Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
High affinity antibodies to human IL-6 receptor
- Patent number 11,370,843
- Issue date Jun 28, 2022
- REGENERON PHARMACEUTICALS, INC.
- Sean Stevens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of suppressing rheumatoid arthritis using an anti-IL-6 anti...
- Patent number 11,180,549
- Issue date Nov 23, 2021
- Janssen Biotech, Inc.
- Yan Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Readily isolated bispecific antibodies with native immunoglobulin f...
- Patent number 11,168,111
- Issue date Nov 9, 2021
- Regeneran Pharmaceuticals, Inc.
- Samuel Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PSMA antibodies, bispecific antigen-binding molecules that bin...
- Patent number 11,155,633
- Issue date Oct 26, 2021
- Regeneran Pharmaceuticals, Inc.
- Jessica R. Kirshner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD3 antibodies, bispecific antigen-binding molecules that bind...
- Patent number 11,155,621
- Issue date Oct 26, 2021
- Regeneran Pharmaceuticals, Inc.
- Eric Smith
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Anti-CD3 antibodies, bispecific antigen-binding molecules that bind...
- Patent number 11,072,656
- Issue date Jul 27, 2021
- Regeneran Pharmaceuticals, Inc.
- Eric Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric antigen receptors specific for B-cell maturation antigen a...
- Patent number 11,066,475
- Issue date Jul 20, 2021
- Juno Therapeutics, Inc.
- Blythe D. Sather
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Anti-CD3 Antibodies, Bispecific Antigen-Binding Molecules that Bind...
- Publication number 20240352124
- Publication date Oct 24, 2024
- Regeneron Pharmaceuticals, Inc.
- Eric Smith
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
METHODS OF USING CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURA...
- Publication number 20240335475
- Publication date Oct 10, 2024
- Memorial Sloan-Kettering Cancer Center
- Renier J. Brentjens
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Non-Human Animals Expressing Humanized CD3 Complex
- Publication number 20240306616
- Publication date Sep 19, 2024
- Regeneron Pharmaceuticals, Inc.
- Kara L. Olson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING G-PROTEIN COUPLED RECEPTOR AND...
- Publication number 20240294599
- Publication date Sep 5, 2024
- Memorial Sloan-Kettering Cancer Center
- Renier J. Brentjens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL ANTIGEN BINDING MOLECULE FORMATS
- Publication number 20240294627
- Publication date Sep 5, 2024
- Regeneron Pharmaceuticals, Inc.
- Tong Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF
- Publication number 20240158529
- Publication date May 16, 2024
- Regeneron Pharmaceuticals, Inc.
- David DiLillo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTERFERON RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20240101633
- Publication date Mar 28, 2024
- Regeneron Pharmaceuticals, Inc.
- Eva-Maria WEICK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF ACTIVATED T-CELLS TO ENHANCE ANTI-TUMOR ACTIVITY OF BISPECIF...
- Publication number 20240091257
- Publication date Mar 21, 2024
- The Johns Hopkins University
- Ivan M. Borrello
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TARGETING G-PROTEIN COUPLED RECEPTOR AND METHODS OF USE
- Publication number 20240076370
- Publication date Mar 7, 2024
- Memorial Sloan-Kettering Cancer Center
- Renier J. Brentjens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTERFERON RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20240067691
- Publication date Feb 29, 2024
- Regeneron Pharmaceuticals, Inc.
- Eva-Maria WEICK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTERLEUKIN-2 PROPROTEINS AND USES THEREOF
- Publication number 20230391844
- Publication date Dec 7, 2023
- Regeneron Pharmaceuticals, Inc.
- Jiaxi WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN-2 PROPROTEINS AND USES THEREOF
- Publication number 20230382969
- Publication date Nov 30, 2023
- Regeneron Pharmaceuticals, Inc.
- Supriya PATEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR UNIVERSAL TUMOR CELL KILLING
- Publication number 20230357446
- Publication date Nov 9, 2023
- Regeneron Pharmaceuticals, Inc.
- Eric Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL ANTIGEN BINDING MOLECULE FORMATS
- Publication number 20230340105
- Publication date Oct 26, 2023
- Regeneron Pharmaceuticals, Inc.
- Tong Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL2 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20230331800
- Publication date Oct 19, 2023
- Regeneron Pharmaceuticals, Inc.
- Jiaxi WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20230312665
- Publication date Oct 5, 2023
- Regeneron Pharmaceuticals, Inc.
- Jiaxi WU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof
- Publication number 20230303696
- Publication date Sep 28, 2023
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heavy Chain Constant Regions with Reduced Binding to Fc Gamma Recep...
- Publication number 20230287117
- Publication date Sep 14, 2023
- Regeneron Pharmaceuticals, Inc.
- Samuel Davis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific Anti-MUC16 x Anti-CD28 Antibodies and Uses Thereof
- Publication number 20230279113
- Publication date Sep 7, 2023
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof
- Publication number 20230272078
- Publication date Aug 31, 2023
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...
- Publication number 20230272111
- Publication date Aug 31, 2023
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods and Antibody Compositions for Tumor Treatment
- Publication number 20230220101
- Publication date Jul 13, 2023
- Regeneron Pharmaceuticals, Inc.
- Eric Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific Anti-CD28 X Anti-CD22 Antibodies and Uses Thereof
- Publication number 20230174652
- Publication date Jun 8, 2023
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGH AFFINITY ANTIBODIES TO HUMAN IL-6 RECEPTOR
- Publication number 20230094591
- Publication date Mar 30, 2023
- Regeneron Pharmaceuticals, Inc.
- Sean Stevens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Multispecific Antigen-Binding Molecules for Cell Targeting and Uses...
- Publication number 20230068129
- Publication date Mar 2, 2023
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20230053563
- Publication date Feb 23, 2023
- Regeneron Pharmaceuticals, Inc.
- Jiaxi WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL12 RECEPTOR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20230051304
- Publication date Feb 16, 2023
- Regeneron Pharmaceuticals, Inc.
- Aaron CHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING FC RECEPTOR-LIKE 5 AND USES TH...
- Publication number 20230020729
- Publication date Jan 19, 2023
- Memorial Sloan-Kettering Cancer Center
- Renier J. Brentjens
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IL2-BASED THERAPEUTICS AND METHODS OF USE THEREOF
- Publication number 20220402989
- Publication date Dec 22, 2022
- Regeneron Pharmaceuticals, Inc.
- Jiaxi Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Readily Isolated Bispecific Antibodies with Native Immunoglobulin F...
- Publication number 20220389055
- Publication date Dec 8, 2022
- Regeneron Pharmaceuticals, Inc.
- Samuel Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

IL2 and peptide-MHC complex fusion proteins and methods of use thereof

Multispecific antigen-binding molecules for cell targeting and uses...

Anti-IL-6 antibody

Multispecific antigen-binding molecules for cell targeting and uses...

Antigen binding molecule formats

Multispecific antigen-binding molecules for cell targeting and uses...

Non-human animals expressing humanized CD3 complex

Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof

Nucleic acid molecules encoding chimeric antigen receptors targetin...

Chimeric antigen receptors targeting G-protein coupled receptor and...

Human antibodies to human delta like ligand 4

IL2 agonists and methods of use thereof

Antibodies targeting B-cell maturation antigen and methods of use

Antigen binding molecule formats

Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific an...

Nucleic acid molecules encoding anti-GPRC5D antibodies

Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof

Heavy chain constant regions with reduced binding to Fc gamma recep...

Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific ant...

Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof

Methods and antibody compositions for tumor treatment

Bispecific anti-CD28 × anti-CD22 antibodies and uses thereof

Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof

High affinity antibodies to human IL-6 receptor

Methods of suppressing rheumatoid arthritis using an anti-IL-6 anti...

Readily isolated bispecific antibodies with native immunoglobulin f...

Anti-PSMA antibodies, bispecific antigen-binding molecules that bin...

Anti-CD3 antibodies, bispecific antigen-binding molecules that bind...

Anti-CD3 antibodies, bispecific antigen-binding molecules that bind...

Chimeric antigen receptors specific for B-cell maturation antigen a...

Patents Applicationslast 30 patents

Anti-CD3 Antibodies, Bispecific Antigen-Binding Molecules that Bind...

METHODS OF USING CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURA...

Non-Human Animals Expressing Humanized CD3 Complex

CHIMERIC ANTIGEN RECEPTORS TARGETING G-PROTEIN COUPLED RECEPTOR AND...

NOVEL ANTIGEN BINDING MOLECULE FORMATS

ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF

INTERFERON RECEPTOR AGONISTS AND USES THEREOF

USE OF ACTIVATED T-CELLS TO ENHANCE ANTI-TUMOR ACTIVITY OF BISPECIF...

ANTIBODIES TARGETING G-PROTEIN COUPLED RECEPTOR AND METHODS OF USE

INTERFERON RECEPTOR AGONISTS AND USES THEREOF

INTERLEUKIN-2 PROPROTEINS AND USES THEREOF

INTERLEUKIN-2 PROPROTEINS AND USES THEREOF

COMPOSITIONS AND METHODS FOR UNIVERSAL TUMOR CELL KILLING

NOVEL ANTIGEN BINDING MOLECULE FORMATS

IL2 AGONISTS AND METHODS OF USE THEREOF

NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF

Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof

Heavy Chain Constant Regions with Reduced Binding to Fc Gamma Recep...

Bispecific Anti-MUC16 x Anti-CD28 Antibodies and Uses Thereof

Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof

Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...

Methods and Antibody Compositions for Tumor Treatment

Bispecific Anti-CD28 X Anti-CD22 Antibodies and Uses Thereof

HIGH AFFINITY ANTIBODIES TO HUMAN IL-6 RECEPTOR

Multispecific Antigen-Binding Molecules for Cell Targeting and Uses...

NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF

IL12 RECEPTOR AGONISTS AND METHODS OF USE THEREOF

CHIMERIC ANTIGEN RECEPTORS TARGETING FC RECEPTOR-LIKE 5 AND USES TH...

IL2-BASED THERAPEUTICS AND METHODS OF USE THEREOF

Readily Isolated Bispecific Antibodies with Native Immunoglobulin F...